Issue 2/1999
Content (11 Articles)
Low dose T-cell lymphocyte infusion combined with marrow T-cell depletion as prophylaxis of acute graft vs host disease for HLA identical sibling bone marrow transplantation
J.Y. Cahn, E. Deconinck, P. Tiberghien, A. Brion, E. Racadot, M. Deschaseaux, R. Angonin, L. Voillat, J. Vuillier, J. Fontan, P. Morel, J.M. Cordonnier, S. Comparot, M.C. Woronoff-Lemsi, P. Hervé
Reticulocytes and solvents an epidemiological study
E. Cardoso, J.-P. Cazenave, H. Schoch, F. Becker, F. Conso
Evaluation of the monocyte counting by the ABX Vega. Comparison with the manual method and fluoro-flow cytometry
M. Morillon, J. Maslin, J-J. De Pina, F.-J. Louisand, G. Martet
Pre-clinical and early clinical experience using dendritic cells to treat human malignancy
L. Kanz, P. Brossart, G. Stuhler, V. Reichardt, A. Kleihauer, S. Scheding, S. Stevanovic, H. Einsele, H.-G. Rammensee, W. Brugger
Tumor cells in breast tumors: significance of their presence for prognosis
L. Edelman, J.-C. Durand, J.P. Lotz, P. Validire, E. Monchâtre, C. Bayle, C. Arnoulet, D. Sainty
Intensification thérapeutique et autogreffe de cellules souches hématopoïétiques (CSH) dans le traitement des cancers du sein métastatiques : résultats du programme national Pegase 04
J.-P. Lotz, H. Curé, M. Janvier, F. Morvan, M. Legros, B. Asselain, M. Guillemot, H. Roché, C. Gisselbrecht
Expansion ex-vivo des cellules hématopoïétiques : étude dans le modèle primate
F. Norol, M. Drouet, N. Debili, W. Vainchenker, F. Herodin
The role of autologous hematopoietic progenitor and cell reinfusion for intensive chemotherapy in women with poor-prognosis breast cancer. Clinical studies with ex-vivo expanded cells produced with the Aastrom Replicell® technology
C. Chabannon, G. Novakovitch, J.-L. Blache, S. Olivero, J. Camerlo, D. Genre, D. Maraninchi, P. Viens
Ex-vivo expansion of hematopoietic progenitor cells: preliminary results in breast cancer
I. McNiece, R. Jones, P. Cagnoni, S. Bearman, Y. Nieto, E.J. Shpall